Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea

References

• Mandell GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingstone/Elsevier; 2009.
   Google Scholar
• Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis 2004; 39:342-8; PMID:15307000; http://dx.doi.org/10.1086/421942
   PubMed Web of Science ®Google Scholar
• Chidiac C, Bruxelle J, Daures JP, Hoang-Xuan T, Morel P, Leplege A, El Hasnaoui A, de Labareyre C. Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis 2001; 33:62-9; PMID:11389496; http://dx.doi.org/10.1086/320884
   PubMed Web of Science ®Google Scholar
• Oster G, Harding G, Dukes E, Edelsberg J, Cleary PD. Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey. J Pain 2005; 6:356-63; PMID:15943957; http://dx.doi.org/10.1016/j.jpain.2005.01.359
   PubMed Web of Science ®Google Scholar
• Song H, Lee J, Lee M, Choi WS, Choi JH, Lee MS, Hashemi M, Rampakakis E, Kawai K, White R, et al. Burden of illness, quality of life, and healthcare utilization among patients with herpes zoster in South Korea: a prospective clinical-epidemiological study. Int J Infect Dis 2014; 20:23-30; PMID:24412314; http://dx.doi.org/10.1016/j.ijid.2013.11.018
   PubMed Web of Science ®Google Scholar
• Helgason S, Petursson G, Gudmundsson S, Sigurdsson JA. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ 2000; 321:794-6; PMID:11009518; http://dx.doi.org/10.1136/bmj.321.7264.794
   PubMed Web of Science ®Google Scholar
• Choo PW, Galil K, Donahue JG, Walker AM, Spiegelman D, Platt R. Risk factors for postherpetic neuralgia. Arch Inter Med 1997; 157:1217-24; http://dx.doi.org/10.1001/archinte.1997.00440320117011
   PubMed Web of Science ®Google Scholar
• Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271-84; PMID:15930418; http://dx.doi.org/10.1056/NEJMoa051016
   PubMed Web of Science ®Google Scholar
• Langan SM, Smeeth L, Margolis DJ, Thomas SL. Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study. PLoS Med 2013; 10:e1001420; PMID:23585738; http://dx.doi.org/10.1371/journal.pmed.1001420
   PubMed Web of Science ®Google Scholar
• Choi WS, Noh JY, Huh JY, Jo YM, Lee J, Song JY, Kim WJ, Cheong HJ. Seroprevalence of varicella-zoster virus in Korea. J Med Virol 2010; 82:2123-6; PMID:20981803; http://dx.doi.org/10.1002/jmv.21917
   PubMedGoogle Scholar
• Yih WK, Brooks DR, Lett SM, Jumaan AO, Zhang Z, Clements KM, Seward JF. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. BMC public Health 2005; 5:68; PMID:15960856; http://dx.doi.org/10.1186/1471-2458-5-68
   PubMed Web of Science ®Google Scholar
• Mullooly JP, Riedlinger K, Chun C, Weinmann S, Houston H. Incidence of herpes zoster, 1997-2002. Epidemiol Infect 2005; 133:245-53; PMID:15816149; http://dx.doi.org/10.1017/S095026880400281X
   PubMed Web of Science ®Google Scholar
• Choi WS, Noh JY, Huh JY, Jo YM, Lee J, Song JY, Kim WJ, Cheong HJ. Disease burden of herpes zoster in Korea. J Clin Virol 2010; 47:325-9; PMID:20181512; http://dx.doi.org/10.1016/j.jcv.2010.01.003
   PubMedGoogle Scholar
• Arvin A. Aging, immunity, and the varicella-zoster virus. N Engl J Med 2005; 352:2266-7; PMID:15930416; http://dx.doi.org/10.1056/NEJMp058091.
   PubMed Web of Science ®Google Scholar
• Statistics Korea. Population Projections for Korea: 2010-2060. Deajeon: Statistics Korea; 2011
   Google Scholar
• Ortman JM, Velkoff VA, Hogan H. An Aging Nation: The Older Population in the United States: Population Estimates and Projections. Washington: US. Census Bureau; 2014. Twenty-eight p. Report No.:P25-1140.
   Google Scholar
• United Nations, Department of Economics and Social Affairs, Population Division. World Population Ageing 2013. New York: United Nations; 2013. Report No.: ST/ESA/SER.A/348.
   Google Scholar
• Korea Centers for Disease Control and Prevention. Guidelines of Vaccination for Adult [Korean]. Cheongju: Korea Centers for Disease Control and Prevention; 2012.
   Google Scholar
• Korea Centers for Disease Control and Prevention. Korea Health Statistics 2012: Korea National Health and Nutrition Examination Survey (KNHANES V-3) [Korean]. Cheongju: Korea Centers for Disease Control and Prevention; 2012.
   Google Scholar
• World Economic and Financial Surveys, World Economic Outlook Database [Internet]. International Monetary Fund; October 2014 [cited 2014 Nov 24]. Available from: http://www.imf.org/external/pubs/ft/weo/2014/02/weodata/index.aspx.
   Google Scholar
• Joon Lee T, Hayes S, Cummings DM, Cao Q, Carpenter K, Heim L, Edwards H. Herpes zoster knowledge, prevalence, and vaccination rate by race. J Am Board Fam Med 2013; 26:45-51; PMID:23288280; http://dx.doi.org/10.3122/jabfm.2013.01.120154
   PubMed Web of Science ®Google Scholar
• Javed S, Javed F, Mays RM, Tyring SK. Herpes zoster vaccine awareness among people >/= 50 years of age and its implications on immunization. Dermatol Online J 2012; 18:2; PMID:22948052
   PubMedGoogle Scholar
• Paek E, Johnson R. Public awareness and knowledge of herpes zoster: results of a global survey. Gerontology 2010; 56:20-31; PMID:19776543; http://dx.doi.org/10.1159/000240046
   PubMed Web of Science ®Google Scholar
• Lu PJ, Euler GL, Jumaan AO, Harpaz R. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors. Vaccine 2009; 27:882-7; PMID:19071175; http://dx.doi.org/10.1016/j.vaccine.2008.11.077
   PubMed Web of Science ®Google Scholar
• Hurley LP, Lindley MC, Harpaz R, Stokley S, Daley MF, Crane LA, Dong F, Beaty BL, Tan L, Babbel C, et al. Barriers to the use of herpes zoster vaccine. Ann Intern Med 2010; 152:555-60; PMID:20439573; http://dx.doi.org/10.7326/0003-4819-152-9-201005040-00005
   PubMed Web of Science ®Google Scholar
• Chow SN, Soon R, Park JS, Pancharoen C, Qiao YL, Basu P, Ngan HY. Knowledge, attitudes, and communication around human papillomavirus (HPV) vaccination amongst urban Asian mothers and physicians. Vaccine 2010; 28:3809-17; PMID:20347631; http://dx.doi.org/10.1016/j.vaccine.2010.03.027
   PubMed Web of Science ®Google Scholar
• Funovits AL, Wagamon KL, Mostow EN, Brodell RT. Refusal of shingles vaccine: implications for public health. J Am Acad Dermatol 2012; 66:1011-2; PMID:22583716; http://dx.doi.org/10.1016/j.jaad.2011.11.931
   PubMedGoogle Scholar
• Opstelten W, van Essen GA, Hak E. Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderly. Vaccine 2009; 27:192-6; PMID:18996427; http://dx.doi.org/10.1016/j.vaccine.2008.10.047
   PubMed Web of Science ®Google Scholar